By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite a $39B backlog, SMCI's equity raise signals a cash crunch and potential dilution risk, with the key unknown being whether capex will lift gross margins and utilization fast enough to justify dilution. The audit failure and governance concerns also pose significant risks.
Risk: The risk of dilution becoming a perpetual drag on shareholder value if capex fails to lift gross margins and utilization fast enough.
Opportunity: The potential for the equity raise to fuel growth if capex is effectively deployed to fulfill orders and improve margins.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Super Micro Computer Shares (SMCI) are dumping on Wednesday as cracks in the AI trade emerge. Shares fell 28% after the company said it would raise $7 billion to fulfill massive demand for its AI servers. That’s $39 billion (!) worth of orders from 20 firms, the company said in a statement, which would very likely be the largest in its history.
To raise the money, the company plans to issue $5 billion in new common and preferred shares, as well as a $2 billion at-the-market offering in July or later against a market cap of about $17.6 billion. Existing shareholders clearly aren’t happy about dilution: SMCI shares fell 36% since Monday, and are down over 5% this year. And this comes after the company’s 2024 scandal when auditor Ernst & Young abruptly resigned and the company was nearly delisted from the Nasdaq.
SMCI’s tumultuous ride shows that AI demand is there, but the cash isn’t, as it and its competitors struggle to keep up with demand. To be fair, Super Micro isn’t the only AI firm raising cash. Google parent Alphabet recently raised $80 billion, upsized to $84.75 billion, to build out the infrastructure it needs to meet its hyperscale goals.
One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.
Chip stocks sold off on Wednesday, as the whole market took a nosedive on President Trump’s Iran saber-rattling and oil prices spiked above $90, rippling through the economy. Micron stock fell about 4%, and AMD fell about 5%, continuing their slide from last week. The S&P 500 and Nasdaq Composite fell about 1.6% and 2% respectively.
And broadly speaking, the AI thesis will be tested as SpaceX (inclusive of xAI), Anthropic, and OpenAI go public over the next few months. If the market can absorb three of the most hyped names in tech at once, it's a green light for the AI trade. If it can't, expect a repricing across the board.
Four leading AI models discuss this article
"Near-term dilution from the $7B capital raise is the dominant risk for SMCI, and the stock’s 28% drop may be a forced repricing until backlog-to-revenue ramp and gross margins prove out."
SMCI's plunge looks like a dilution kicker reverse of the AI demand hype. The narrative that 'AI demand is there but cash isn't' ignores that a $5B equity raise plus a $2B ATM signals a heavy capex program to scale manufacturing, not a loss of demand. The key unknowns: what portion of the $39B backlog is immediate vs. multiyear, and what margins and working capital the ramp will imply. The stock's fall could overstate dilution risk if the proceeds accelerate revenue and free cash flow; but if orders disappoint or utilization lags, the dilution will pressure margins and optionality. The broader AI hype cycle and hyperscale capex risk remain the real wildcards.
Even with a real backlog, the ramp costs and ongoing dilution could crush near-term earnings; the market may reprice SMCI further if cash burn or utilization stay weak, making the 'AI demand' narrative less reliable than the headlines suggest.
"SMCI’s massive dilution plan confirms that AI hardware manufacturing is a capital-intensive commodity business rather than a high-margin software-like growth engine."
The market is correctly punishing SMCI for a desperate capital structure move. Attempting to raise $7 billion against a $17.6 billion market cap is massive dilution, signaling that the company's working capital requirements are outstripping its ability to generate free cash flow. This isn't just 'growing pains'; it’s a liquidity crunch. The comparison to Alphabet’s debt issuance is disingenuous—Alphabet has a fortress balance sheet, whereas SMCI is currently fighting for its life with auditors and Nasdaq compliance. The real risk here is that the AI hardware 'pick and shovel' business model is proving to be a low-margin, capital-intensive trap rather than the high-moat software play investors initially priced in.
If SMCI successfully secures this capital, they could effectively corner the supply chain for liquid-cooled server racks, creating a massive barrier to entry that competitors like Dell cannot replicate quickly.
"SMCI's capital raise reveals a structural problem (AI server makers are capex-constrained, not demand-constrained), but the 28% drop conflates two separate issues—demand strength and shareholder dilution—and overshoots on panic."
SMCI's 28% drop is being framed as AI demand weakness, but it's actually the opposite: $39B in backlog proves demand is ravenous. The real issue is SMCI's balance sheet can't support capex to fulfill orders—hence the dilutive raise. This is a working-capital crisis masquerading as a demand crisis. The 36% two-day drop is overdone panic. However, the dilution math is brutal: $7B raise against $17.6B market cap (~40% dilution) will compress per-share value significantly even if revenue scales. The 2024 audit scandal also means execution risk is priced in at zero, which seems naive.
If SMCI can't raise $7B without cratering its stock, maybe the market is signaling that the $39B backlog isn't as credible as management claims—especially post-EY resignation. Demand without the ability to finance fulfillment is just noise.
"Dilution from the $7B raise will outweigh the $39B order signal and pressure SMCI shares further given its cash constraints and history."
SMCI's plan to raise $7B via equity and ATM offerings against a $17.6B market cap signals acute cash needs despite $39B in claimed orders from 20 customers. This dilution, on top of the 2024 EY resignation and near-delisting, risks further erosion of shareholder value even if demand proves real. The broader chip selloff tied to oil spikes and Iran rhetoric compounds near-term pressure, while upcoming AI IPOs could expose valuation limits across the sector. Execution on fulfillment and margins will determine if this raise fuels growth or merely sustains operations.
The $39B backlog could convert into revenue far exceeding the dilution impact if supply chains scale rapidly, potentially driving EPS growth that supports a higher multiple once cash is deployed.
"The critical test is capex-driven margin and utilization, not the size of the raise; dilution only hurts if backlog conversion and working-capital dynamics disappoint."
Gemini's emphasis on liquidity is valid, but the real risk isn’t merely the cash raise—it's whether capex actually lifts gross margins and utilization fast enough to justify diluting equity. A big raise can fail to re-rate if backlog-to-revenue conversion, supplier terms, and working-capital cycles lag. If those dynamics stay weak, the dilution becomes a perpetual drag; the market will demand visible, near-term green shoots beyond confident rhetoric about 'desperate capital'.
"The audit failure renders the backlog unverifiable and forces dilutive financing, making the stock uninvestable until governance is restored."
Claude, you’re glossing over the audit failure. A $39B backlog is meaningless if the company cannot produce audited financials to satisfy institutional lenders, forcing them into this predatory equity dilution. This isn't just a 'working-capital crisis'; it’s a governance black hole. Until the EY resignation is resolved and internal controls are verified, the market is right to treat the backlog as a hypothetical rather than a bankable asset. The dilution is the symptom, not the disease.
"Audit failures explain the dilution severity but don't invalidate the backlog; institutional participation in the raise is the real signal of credibility."
Gemini's audit-as-dealbreaker framing is overstated. Yes, EY's resignation signals control gaps, but SMCI already disclosed the issues and is remediating. The real tell: institutional investors are apparently willing to participate in this raise despite audit risk, suggesting they believe the backlog is bankable enough. If the backlog were purely hypothetical, the raise wouldn't close at any price. The liquidity crunch is real, but it's not proof the orders are fake.
"Institutional participation does not prove backlog credibility amid unresolved audit risks."
Claude assumes institutional buyers validate the $39B backlog, yet distressed equity raises often attract vulture funds betting on survival discounts rather than verified demand. With EY remediation still pending, any commitments remain conditional on unproven controls, risking deal collapse or harsher terms that compound the 40% dilution. This directly ties Gemini's governance gap to fulfillment failure.
Despite a $39B backlog, SMCI's equity raise signals a cash crunch and potential dilution risk, with the key unknown being whether capex will lift gross margins and utilization fast enough to justify dilution. The audit failure and governance concerns also pose significant risks.
The potential for the equity raise to fuel growth if capex is effectively deployed to fulfill orders and improve margins.
The risk of dilution becoming a perpetual drag on shareholder value if capex fails to lift gross margins and utilization fast enough.